Bulletin
Investor Alert

London Markets Open in:

Biogen Inc.

NAS: BIIB

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 30, 2022, 7:55 p.m.

/zigman2/quotes/201531540/composite

$

306.50

Change

+1.33 +0.44%

Volume

Volume 314,107

Quotes are delayed by 20 min

/zigman2/quotes/201531540/composite

Previous close

$ 291.41

$ 305.17

Change

+13.76 +4.72%

Day low

Day high

$301.20

$311.88

Open

52 week low

52 week high

$187.16

$311.88

Open

Insider Actions for Biogen Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
10/27/2022 Susan H. Alexander
EVP Chief Legal Off & Corp Sec
5,532   Disposition at $280.7 per share. 1,552,832
09/01/2022 Michael R. McDonnell
EVP, Chief Financial Officer
1,056   Derivative/Non-derivative trans. at $199.79 per share. 210,978
09/01/2022 Michael R. McDonnell
EVP, Chief Financial Officer
1,372   Derivative/Non-derivative trans. at $199.79 per share. 274,111
09/01/2022 Michael R. McDonnell
EVP, Chief Financial Officer
2,064   Derivative/Non-derivative trans. at $0 per share. 0
09/01/2022 Michael R. McDonnell
EVP, Chief Financial Officer
2,682   Derivative/Non-derivative trans. at $0 per share. 0
08/01/2022 Nicole Murphy
Head of Pharm Ops and Tech
243   Derivative/Non-derivative trans. at $209.26 per share. 50,850
08/01/2022 Nicole Murphy
Head of Pharm Ops and Tech
76   Derivative/Non-derivative trans. at $209.26 per share. 15,903
08/01/2022 Nicole Murphy
Head of Pharm Ops and Tech
825   Derivative/Non-derivative trans. at $0 per share. 0
08/01/2022 Nicole Murphy
Head of Pharm Ops and Tech
255   Derivative/Non-derivative trans. at $0 per share. 0
07/01/2022 Rachid Izzar
Head of Alzheimer s Disease
148   Derivative/Non-derivative trans. at $210.63 per share. 31,173
07/01/2022 Robin C. Kramer
Chief Accounting Officer
74   Derivative/Non-derivative trans. at $210.63 per share. 15,586
07/01/2022 Rachid Izzar
Head of Alzheimer s Disease
504   Derivative/Non-derivative trans. at $0 per share. 0
07/01/2022 Robin C. Kramer
Chief Accounting Officer
252   Derivative/Non-derivative trans. at $0 per share. 0
06/15/2022 Stelios Papadopoulos
Director
2,255   Award at $0 per share. 0
06/15/2022 Caroline D. Dorsa
Director
1,370   Award at $0 per share. 0
06/15/2022 Eric K. Rowinsky
Director
1,370   Award at $0 per share. 0
06/15/2022 Stephen A. Sherwin
Director
1,370   Award at $0 per share. 0
06/15/2022 Alexander John Denner
Director
1,370   Award at $0 per share. 0
06/15/2022 Richard Charles Mulligan
Director
1,370   Award at $0 per share. 0
06/15/2022 Jesus B. Mantas
Director
1,370   Award at $0 per share. 0
06/15/2022 William A. Hawkins
Director
1,370   Award at $0 per share. 0
06/15/2022 William D. Jones
Director
1,370   Award at $0 per share. 0
06/15/2022 Maria C. Freire
Director
1,370   Award at $0 per share. 0
04/01/2022 Nicole Murphy
Head of Pharm Ops and Tech
84   Derivative/Non-derivative trans. at $210.65 per share. 17,694
04/01/2022 Nicole Murphy
Head of Pharm Ops and Tech
239   Derivative/Non-derivative trans. at $0 per share. 0
02/18/2022 Michel Vounatsos
Chief Executive Officer; Director
2,746   Derivative/Non-derivative trans. at $209.79 per share. 576,083
02/18/2022 Susan H. Alexander
EVP Chief Legal Off & Corp Sec
659   Derivative/Non-derivative trans. at $209.79 per share. 138,251
02/18/2022 Ginger Gregory
EVP, Human Resources
616   Derivative/Non-derivative trans. at $209.79 per share. 129,230
02/18/2022 Chirfi Guindo
Head of Glob Prod Strat & Com
879   Derivative/Non-derivative trans. at $209.79 per share. 184,405
02/18/2022 Michael R. McDonnell
EVP, Chief Financial Officer
977   Derivative/Non-derivative trans. at $209.79 per share. 204,964
02/18/2022 Nicole Murphy
Head of Pharm Ops and Tech
110   Derivative/Non-derivative trans. at $209.79 per share. 23,076
02/18/2022 Rachid Izzar
Head of Alzheimer s Disease
175   Derivative/Non-derivative trans. at $209.79 per share. 36,713
02/18/2022 Robin C. Kramer
Chief Accounting Officer
117   Derivative/Non-derivative trans. at $209.79 per share. 24,545
02/18/2022 Michel Vounatsos
Chief Executive Officer; Director
6,191   Derivative/Non-derivative trans. at $0 per share. 0
02/18/2022 Susan H. Alexander
EVP Chief Legal Off & Corp Sec
1,485   Derivative/Non-derivative trans. at $0 per share. 0
02/18/2022 Ginger Gregory
EVP, Human Resources
1,387   Derivative/Non-derivative trans. at $0 per share. 0
02/18/2022 Chirfi Guindo
Head of Glob Prod Strat & Com
1,981   Derivative/Non-derivative trans. at $0 per share. 0
02/18/2022 Michael R. McDonnell
EVP, Chief Financial Officer
1,981   Derivative/Non-derivative trans. at $0 per share. 0
02/18/2022 Nicole Murphy
Head of Pharm Ops and Tech
371   Derivative/Non-derivative trans. at $0 per share. 0
02/18/2022 Rachid Izzar
Head of Alzheimer s Disease
594   Derivative/Non-derivative trans. at $0 per share. 0
02/18/2022 Robin C. Kramer
Chief Accounting Officer
396   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2022 Michel Vounatsos
Chief Executive Officer; Director
4,699   Derivative/Non-derivative trans. at $214.59 per share. 1,008,358
02/12/2022 Michel Vounatsos
Chief Executive Officer; Director
1,950   Derivative/Non-derivative trans. at $214.59 per share. 418,450
02/12/2022 Michel Vounatsos
Chief Executive Officer; Director
1,917   Derivative/Non-derivative trans. at $214.59 per share. 411,369
02/12/2022 Susan H. Alexander
EVP Chief Legal Off & Corp Sec
1,044   Derivative/Non-derivative trans. at $214.59 per share. 224,031
02/12/2022 Susan H. Alexander
EVP Chief Legal Off & Corp Sec
500   Derivative/Non-derivative trans. at $214.59 per share. 107,295
02/12/2022 Susan H. Alexander
EVP Chief Legal Off & Corp Sec
512   Derivative/Non-derivative trans. at $214.59 per share. 109,870
02/12/2022 Ginger Gregory
EVP, Human Resources
584   Derivative/Non-derivative trans. at $214.59 per share. 125,320
02/12/2022 Ginger Gregory
EVP, Human Resources
390   Derivative/Non-derivative trans. at $214.59 per share. 83,690
02/12/2022 Ginger Gregory
EVP, Human Resources
278   Derivative/Non-derivative trans. at $214.59 per share. 59,656
02/12/2022 Chirfi Guindo
Head of Glob Prod Strat & Com
1,189   Derivative/Non-derivative trans. at $214.59 per share. 255,147
02/12/2022 Chirfi Guindo
Head of Glob Prod Strat & Com
593   Derivative/Non-derivative trans. at $214.59 per share. 127,251
02/12/2022 Chirfi Guindo
Head of Glob Prod Strat & Com
560   Derivative/Non-derivative trans. at $214.59 per share. 120,170
02/12/2022 Nicole Murphy
Head of Pharm Ops and Tech
92   Derivative/Non-derivative trans. at $214.59 per share. 19,742
02/12/2022 Rachid Izzar
Head of Alzheimer s Disease
122   Derivative/Non-derivative trans. at $214.59 per share. 26,179
02/12/2022 Robin C. Kramer
Chief Accounting Officer
85   Derivative/Non-derivative trans. at $214.59 per share. 18,240
02/12/2022 Robin C. Kramer
Chief Accounting Officer
51   Derivative/Non-derivative trans. at $214.59 per share. 10,944
02/12/2022 Robin C. Kramer
Chief Accounting Officer
35   Derivative/Non-derivative trans. at $214.59 per share. 7,510
02/12/2022 Michel Vounatsos
Chief Executive Officer; Director
4,395   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2022 Michel Vounatsos
Chief Executive Officer; Director
4,321   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2022 Susan H. Alexander
EVP Chief Legal Off & Corp Sec
1,126   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2022 Susan H. Alexander
EVP Chief Legal Off & Corp Sec
1,154   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2022 Ginger Gregory
EVP, Human Resources
879   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2022 Ginger Gregory
EVP, Human Resources
793   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2022 Chirfi Guindo
Head of Glob Prod Strat & Com
1,336   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2022 Chirfi Guindo
Head of Glob Prod Strat & Com
1,261   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2022 Nicole Murphy
Head of Pharm Ops and Tech
263   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2022 Rachid Izzar
Head of Alzheimer s Disease
351   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2022 Robin C. Kramer
Chief Accounting Officer
176   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2022 Robin C. Kramer
Chief Accounting Officer
99   Derivative/Non-derivative trans. at $0 per share. 0
01/19/2022 Michel Vounatsos
Chief Executive Officer; Director
10,594   Award at $0 per share. 0
01/19/2022 Susan H. Alexander
EVP Chief Legal Off & Corp Sec
2,825   Award at $0 per share. 0
01/19/2022 Ginger Gregory
EVP, Human Resources
1,941   Award at $0 per share. 0
01/19/2022 Chirfi Guindo
Head of Glob Prod Strat & Com
3,088   Award at $0 per share. 0
01/19/2022 Alphonse Galdes
EVP Pharmaceutical Oper & Tech
658   Award at $0 per share. 0
01/19/2022 Robin C. Kramer
Chief Accounting Officer
244   Award at $0 per share. 0
12/03/2021 Robin C. Kramer
Chief Accounting Officer
22   Derivative/Non-derivative trans. at $223.92 per share. 4,926
12/03/2021 Robin C. Kramer
Chief Accounting Officer
78   Derivative/Non-derivative trans. at $223.92 per share. 17,465
12/03/2021 Robin C. Kramer
Chief Accounting Officer
265   Derivative/Non-derivative trans. at $223.92 per share. 59,338
12/03/2021 Robin C. Kramer
Chief Accounting Officer
74   Derivative/Non-derivative trans. at $223.92 per share. 16,570

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
1 Sales
0
5,532
Last 6 months
16 Purchases
7 Sales
21,167
8,501
Last 12 months
46 Purchases
36 Sales
72,007
29,730

Officers and Executives

Mr. Michel Vounatsos
Chief Executive Officer & Director
Dr. Alphonse Galdes
EVP-Pharmaceutical Operations & Technology
Mr. Michael R. McDonnell
Chief Financial Officer & Executive Vice President
Dr. Mahalakshmi Radhakrishnan
Chief Medical Officer & Group Senior VP
Dr. Priya Singhal
Head-Research & Development
Dr. Rohin Mhatre
Senior VP-Product & Technology Development
Dr. Jake Elkins
Vice President & Head-Acute Neurology Research
Mr. Rachid Izzar
Executive Vice President
Mr. Robert Kilo
Account Director
Dr. Anabella Villalobos
SVP-Biotherapeutic & Medicinal Sciences
Mr. Michael Dambach
Treasurer & Vice President
Ms. Robin C. Kramer
Chief Accounting Officer & Senior Vice President
Mr. Michael Hencke
Director-Investor Relations
Dr. Ginger Gregory
Chief Human Resources Officer & Executive VP
Ms. Susan H. Alexander
Secretary, Chief Legal Officer & Executive VP
Mr. Wendell C. Taylor
Chief Corporation Counsel & Assistant Secretary
Dr. Stelios Papadopoulos
Chairman
Mr. William A. Hawkins
Independent Director
Mr. Jesus B. Mantas
Independent Director
Dr. Maria C. Freire
Independent Director
Mr. William D. Jones
Independent Director
Dr. Alexander John Denner
Independent Director
Dr. Richard Charles Mulligan
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Eric K. Rowinsky
Independent Director
Dr. Stephen A. Sherwin
Independent Director
Link to MarketWatch's Slice.